Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer

This study has been completed.
Cancer and Leukemia Group B
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: January 24, 2003
Last updated: October 7, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)